Introduction Staphylococcal pleuropulmonary disease (SPP) is an infectious pathology caused by Staphylococcus aureus, a germ responsible for a wide range of suppurative, toxigenic and multifocal infections (cutaneous, osteoarticular, pulmonary, etc.). This entity is most often associated with staphylococcal acute community-acquired pneumonia, the prevalence of which remains low at 2-5% 1. It mainly affects the elderly, people living in institutions or with co-morbidities. Recent studies have shown that the epidemiological profile of this infection is rejuvenated by the characteristics of certain strains of Staphylococcus aureus, notably those that secrete a synergohymenotropic toxin known as Panton-Valentine Leukocidin (PVL) 1. We report a case of pleuropulmonary staphylococcal disease in a young immunocompetent subject with a cutaneous onset and a favourable course.
M et al. (Fri,) studied this question.